1. Home
  2. LEGN vs PSN Comparison

LEGN vs PSN Comparison

Compare LEGN & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • PSN
  • Stock Information
  • Founded
  • LEGN 2014
  • PSN 1944
  • Country
  • LEGN United States
  • PSN United States
  • Employees
  • LEGN N/A
  • PSN N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • PSN EDP Services
  • Sector
  • LEGN Health Care
  • PSN Technology
  • Exchange
  • LEGN Nasdaq
  • PSN Nasdaq
  • Market Cap
  • LEGN 5.4B
  • PSN 6.8B
  • IPO Year
  • LEGN 2020
  • PSN 2019
  • Fundamental
  • Price
  • LEGN $37.84
  • PSN $74.70
  • Analyst Decision
  • LEGN Strong Buy
  • PSN Strong Buy
  • Analyst Count
  • LEGN 12
  • PSN 11
  • Target Price
  • LEGN $73.82
  • PSN $84.30
  • AVG Volume (30 Days)
  • LEGN 1.8M
  • PSN 1.2M
  • Earning Date
  • LEGN 08-08-2025
  • PSN 08-06-2025
  • Dividend Yield
  • LEGN N/A
  • PSN N/A
  • EPS Growth
  • LEGN N/A
  • PSN 50.29
  • EPS
  • LEGN N/A
  • PSN 2.35
  • Revenue
  • LEGN $728,303,000.00
  • PSN $6,769,260,000.00
  • Revenue This Year
  • LEGN $65.49
  • PSN N/A
  • Revenue Next Year
  • LEGN $53.76
  • PSN $3.19
  • P/E Ratio
  • LEGN N/A
  • PSN $31.86
  • Revenue Growth
  • LEGN 112.46
  • PSN 16.61
  • 52 Week Low
  • LEGN $27.34
  • PSN $54.56
  • 52 Week High
  • LEGN $60.87
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 65.70
  • PSN 67.88
  • Support Level
  • LEGN $34.64
  • PSN $73.85
  • Resistance Level
  • LEGN $36.91
  • PSN $77.98
  • Average True Range (ATR)
  • LEGN 1.48
  • PSN 1.74
  • MACD
  • LEGN 0.18
  • PSN 0.48
  • Stochastic Oscillator
  • LEGN 90.94
  • PSN 72.48

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: